ERS/ESRS成人阻塞性睡眠呼吸暂停持续气道正压通气治疗临床实践指南
该指南由欧洲呼吸学会与欧洲睡眠研究学会联合制定,采用PICO框架和GRADE方法系统评价CPAP对以患者为中心及预后相关结局的影响。推荐对伴日间过度嗜睡的OSA患者使用CPAP(强推荐),对其他亚组则根据症状和合并症给出条件性推荐或不治疗的建议。
要点
- 伴日间过度嗜睡的OSA患者强烈推荐CPAP治疗。
- 一般建议CPAP治疗OSA,基于对嗜睡、患者报告结局和血压的获益(条件性推荐)。
- 无日间过度嗜睡者、房颤患者及糖代谢异常者的CPAP推荐为条件性,需个体化权衡。
核心结论
- CPAP是成人OSA的有效治疗,但不同患者亚组的推荐不同。
研究设计与样本
- 联合ERS/ESRS工作组由呼吸、心脏和呼吸睡眠医学专家、患者代表及方法学家组成,采用PICO框架提出问题。
- 进行了系统评价评估CPAP对关键结局的影响,并使用GRADE方法评估证据确定性。
- 通过Evidence-to-Decision框架和讨论投票达成推荐方向和强度的共识。
主要发现
- CPAP对嗜睡、其他患者报告结局和血压有有益影响。
- CPAP在日间过度嗜睡患者中获强推荐。
- 对中重度OSA、老年人、动脉性高血压和难治性高血压患者给出特定的条件性推荐。
- 对无日间过度嗜睡者、房颤患者(以减少复发为目标)和糖代谢异常者(以改善血糖控制为目标),建议CPAP或不治疗均可。
关键数值与推荐
- 伴日间过度嗜睡的OSA患者:强推荐CPAP。
- 一般OSA患者:条件性推荐CPAP,基于对嗜睡、患者报告结局和血压的获益。
- 中重度OSA、老年人、动脉性高血压和难治性高血压患者:附加特定条件性推荐。
- 无日间过度嗜睡者(需考虑其他OSA相关症状)、房颤患者(减少复发)和糖代谢异常者(改善血糖控制):建议CPAP或不治疗。
临床怎么用
- 对伴日间过度嗜睡的OSA成人应强推荐CPAP治疗。
- 对无日间过度嗜睡者需评估其他OSA相关症状后再决定是否CPAP。
- 对房颤或糖代谢异常患者,CPAP的目标分别为减少复发和改善血糖控制,但推荐为条件性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnoea (OSA), although its effectiveness may vary across OSA subtypes. This joint European Respiratory Society (ERS)/European Sleep Research Society (ESRS) clinical practice guideline evaluates CPAP's impact on patient-centred and prognostically relevant outcomes, comparing it to no or sham treatment in different OSA subgroups. METHODS: The joint ERS/ESRS Task Force consisted of experts in pulmonology, cardiology and respiratory sleep medicine, patient representatives and methodologists. Questions were formulated using the PICO (Population, Intervention, Comparator, Outcomes) framework. A systematic review assessing the effects of CPAP on critical outcomes was performed. The certainty of evidence for all outcomes was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Consensus on the direction and strength of the recommendation was informed by Evidence-to-Decision frameworks and achieved through discussions and voting. RECOMMENDATIONS: The Task Force generally suggests CPAP treatment for OSA because of its beneficial effects on sleepiness, other patient-reported outcomes and blood pressure (conditional recommendations). CPAP is recommended in patients with excessive daytime sleepiness (EDS) (strong recommendation). Additional specific conditional recommendations are given for patients with moderate-to severe OSA, the elderly, and patients with arterial and treatment-resistant hypertension. The Task Force suggests either CPAP or no treatment in patients without EDS (but taking into account other OSA-related symptoms), in patients with atrial fibrillation with the aim of reducing its recurrence and in patients with impaired glucose metabolism to improve glycaemic control. CONCLUSION: CPAP is an effective treatment for adults with OSA. However, recommendations for its use vary across different patient subgroups.
引用
- Testelmans D, Schwarz EI, Anttalainen U, et al. ERS/ESRS clinical practice guideline for continuous positive airway pressure for the treatment of adult obstructive sleep apnoea. Eur Respir J. 2026. PMID: 42860272. doi:10.1183/13993003.01186-2026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。